Versant Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Versant Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-742	Closed	-$15.9K	–	2780
2026 Q1	$15.9K	Buy	742 +138	+23%	+$1.95K	﹤0.01%	1929
2025 Q4	$5.63K	Hold	604	–	–	﹤0.01%	2211
2025 Q3	$4.26K	Hold	604	–	–	﹤0.01%	2267
2025 Q2	$3.93K	Buy	+604	New	+$4.16K	﹤0.01%	2242

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Versant Capital Management's DAWN Position: Q2 2026 in Review

Versant Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 742 shares — an estimated $15.9K sold.

Versant Capital Management first reported a position in DAWN in Q2 2025 and held it in 4 quarters. The position peaked at $15.9K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Versant Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Versant Capital Management sold 742 Day One Biopharmaceuticals shares in Q2 2026, an estimated $15.9K.
Versant Capital Management first reported a position in Day One Biopharmaceuticals in Q2 2025 and held it in 4 quarters.
Versant Capital Management's Day One Biopharmaceuticals position peaked at $15.9K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.